在癌症中催化氧化诱导的神经病痛:动物模型和相关研究进展
Yuxin Jiang1,2, Jie Shi3, Wenping Wang2
1Liaoning University of Traditional Chinese Medicine, Shenyang, Liaoning, China.
Frontiers in pharmacology
|June 16, 2025
概括
在癌症幸存者中,氧化化疗可以引起神经疼痛 (CIPNP). 本文审查了动物模型,以更好地理解和治疗这种痛苦的副作用.
科学领域:
- 在瘤学瘤学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 奥克沙利是癌症治疗的关键化疗剂.
- 化疗诱导的周围神经病痛 (CIPNP) 是氧沙的显著,使人衰弱的副作用.
- 目前对CIPNP机制和杜洛西丁等有效治疗方法的理解需要进一步的研究.
研究的目的:
- 审查和巩固最近在动物模型中对氧化诱导的CIPNP的进展.
- 提高现有动物模型的成功率和准确性.
- 促进对CIPNP机制,进展和潜在治疗策略的研究.
主要方法:
- 对和小鼠模型的当前文献的综述 氧沙诱导的CIPNP.
- 分析用于开发和验证这些模型的方法.
- 综合与模拟人类CIPNP症状的模型忠实性相关的发现.
主要成果:
- 确定在为CIPNP创造更精确的动物模型方面取得的关键进展.
- 评估这些模型在研究神经病痛机制方面的实用性.
- 强调需要模型,准确反映疾病进展和临床表现.
结论:
- 改进的动物模型对于推进氧沙胺诱导的神经病痛的研究至关重要.
- 这些模型将有助于为癌症幸存者开发更有效的止痛策略和治疗方法.
- 对建模技术的进一步研究对于提高临床相关性和药物开发至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
267
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
267
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K


